Pulmatrix Inc.

Pulmatrix Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$7.51 M
Shares Outstanding
18.29 M
Public Float
7.68 M


99 Hayden Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.pulmatrix.com
Updated 07/08/2019
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The company focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.


View All

Robert W. Clarke
President, Chief Executive Officer & Director
Mark T. Iwicki